Patient A is a year-old male who was admitted to the hospital from home after 1 week of cough, profuse nocturnal sweating, loss of appetite and hyposomnia. He was seen by an emergency room physician who noted signs of depression. The patient has a history of intravenous drug abuse and hepatitis B. Patient A was originally administered isoniazid, rifampin, pyrazinamide, and ethambutol for 7 days per week for 8 weeks, followed by isoniazid and rifampin 7 days per week for 24 weeks. In addition to hemoptysis, he revealed that, since his previous visit, he had continued to feel malaise, was continuing to lose weight, and had been experiencing night sweats.
Officially launched in , Virgin Voyages is the Virgin Group's brand set to disrupt the cruise sector by offering a product aimed at the younger cruise demographic. Bringing the Virgin flair and playfulness that has been seen across its airline and holiday business, the cruise line will provide a fresh perspective to cruising and be well-positioned to attract the rising demand from younger cruisers. Virgin Voyages has set out a bold vision by adjusting many longstanding traditions typically associated with cruise tourism. Firstly, the company is opting for smaller ships and not deploying megaships, with the aim of offering a higher level of service on board. With a total of 1, cabins and 78 Rockstars suites onboard the first ship Scarlet Lady, plans are for it to meet the needs of a variety of travelers.